Insider · CIK 0001197020

SATO VICKI L

Reports to the SEC for 11 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001197020

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-18	ALLOAllogene Therapeutics, Inc. · Restricted Stock UnitA Award	Director	AAward	+95.4K sh	—	—	95,400
2026-05-01	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−22K sh	$10.05	−$221K	1,078,391
2026-04-01	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−22K sh	$9.07	−$200K	1,100,391
2026-03-02	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−21.8K sh	$9.50	−$207K	1,122,591
2026-03-02	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−200 sh	$9.98	−$1,996	1,122,391
2026-02-24	VIRVir Biotechnology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+42.4K sh	$1.49	+$62.9K	1,186,768
2026-02-24	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−42.2K sh	$9.75	−$411K	1,144,591
2026-02-24	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−200 sh	$10.26	−$2,052	1,144,391
2026-02-24	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−42.4K sh	—	—	0
2026-02-02	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−22K sh	$7.71	−$170K	1,144,391
2026-01-02	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−22K sh	$5.93	−$130K	1,166,391
2025-12-01	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−22K sh	$6.00	−$132K	1,188,391
2025-11-03	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−22K sh	$5.64	−$124K	1,210,391
2025-10-01	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−22K sh	$5.84	−$128K	1,232,391
2025-09-02	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−22K sh	$4.99	−$110K	1,254,391
2025-08-01	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−22K sh	$4.99	−$110K	1,276,391
2025-07-01	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−22K sh	$5.10	−$112K	1,298,391
2025-06-18	ALLOAllogene Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director	AAward	+144K sh	—	—	144,400
2025-05-30	VIRVir Biotechnology, Inc.A Award	Director	AAward	+8,000 sh	—	—	1,320,391
2025-05-30	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,000
2025-01-08	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−11K sh	$12.52	−$137K	1,312,391
2025-01-02	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−3,080 sh	$20.91	−$64.4K	107,976
2024-11-07	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−1,020 sh	$30.00	−$30.6K	111,056
2024-11-01	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−3,080 sh	$27.07	−$83.4K	112,076
2024-09-13	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−1,020 sh	$30.00	−$30.6K	115,156
2024-09-03	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−2,980 sh	$24.99	−$74.5K	116,276
2024-09-03	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−100 sh	$25.37	−$2,537	116,176
2024-07-01	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−2,980 sh	$22.12	−$65.9K	119,356
2024-07-01	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−100 sh	$22.86	−$2,286	119,256
2024-06-05	ALLOAllogene Therapeutics, Inc.A Award	Director	AAward	+61.5K sh	—	—	162,575
2024-06-05	ALLOAllogene Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director	AAward	+95.5K sh	—	—	95,541
2024-05-31	DNLIDenali Therapeutics Inc.A Award	Director	AAward	+5,967 sh	—	—	122,336
2024-05-31	DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.9K sh	—	—	17,901
2024-05-30	VIRVir Biotechnology, Inc.A Award	Director	AAward	+8,000 sh	—	—	1,323,351
2024-05-30	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,000
2024-05-15	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−1,674 sh	$20.39	−$34.1K	116,369
2024-04-15	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−1,666 sh	$18.29	−$30.5K	118,043
2024-03-15	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−1,666 sh	$20.10	−$33.5K	119,709
2024-02-15	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−1,666 sh	$18.37	−$30.6K	121,375
2024-01-16	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−1,666 sh	$18.42	−$30.7K	123,041
2023-12-15	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−1,666 sh	$23.39	−$39K	124,707
2023-11-15	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−1,666 sh	$19.13	−$31.9K	126,373
2023-10-16	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−1,666 sh	$20.66	−$34.4K	128,039
2023-09-15	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−1,626 sh	$23.60	−$38.4K	129,745
2023-09-15	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−40 sh	$24.35	−$974	129,705
2023-08-15	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−1,666 sh	$24.30	−$40.5K	131,371
2023-07-17	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−1,666 sh	$29.60	−$49.3K	133,037
2023-06-30	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−18K sh	$24.66	−$444K	1,315,351
2023-06-28	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−552 sh	$29.55	−$16.3K	135,817
2023-06-28	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−1,114 sh	$29.98	−$33.4K	134,703

Recent filings

Accepted (ET)
Jun 234
SATO VICKI L0001197020-26-000002
SEC(opens sec.gov)
May 44
SATO VICKI L0001628280-26-029640
SEC(opens sec.gov)
Apr 24
SATO VICKI L0001628280-26-022971
SEC(opens sec.gov)
Mar 34
SATO VICKI L0001628280-26-013630
SEC(opens sec.gov)
Feb 264
SATO VICKI L0001628280-26-012397
SEC(opens sec.gov)
Feb 34
SATO VICKI L0001628280-26-004866
SEC(opens sec.gov)
Jan 54
SATO VICKI L0001628280-26-000320
SEC(opens sec.gov)
Dec 24
SATO VICKI L0001628280-25-054884
SEC(opens sec.gov)
Nov 44
SATO VICKI L0001628280-25-048624
SEC(opens sec.gov)
Oct 24
SATO VICKI L0001628280-25-043567
SEC(opens sec.gov)
Sep 34
SATO VICKI L0001197020-25-000005
SEC(opens sec.gov)
Aug 44
SATO VICKI L0001628280-25-037344
SEC(opens sec.gov)
Jul 24
SATO VICKI L0001628280-25-034055
SEC(opens sec.gov)
Jun 234
SATO VICKI L0001737287-25-000077
SEC(opens sec.gov)
Jun 24
SATO VICKI L0001628280-25-028900
SEC(opens sec.gov)

Companies

Address

210 EAST GRAND AVENUE

SOUTH SAN FRANCISCO, CA, 94080